Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06232876 · ClinicalTrials.gov registry record · NA

Continuous Versus Intermittent Ward Monitoring

A NA study, sponsored by The University of Texas Health Science Center, Houston.

Not yet
Registry status
NA
Development phase
492
Enrollment target

NCT06232876 is a NA study that has not yet begun recruiting, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 492 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06232876, a NA study, has not yet begun recruiting, sponsored by The University of Texas Health Science Center, Houston.

NOT YET RECRUITING
Registry status
NA
Development phase
492 participants
Enrollment target

Study Summary

The investigators will randomize adults having major non-cardiac inpatient surgery to blinded versus unblinded continuous postoperative vital sign monitoring (saturation, ventilation, and heart rate). The investigators will use a wearable, untethered, and battery-powered sensor (Masimo Radius PPG, Masimo, Irvine, CA) that wirelessly connects to a Masimo monitor and continuously records saturation, ventilation, and pulse rate. The primary outcome will be areas-exceeding-thresholds for desaturation (\<85%), bradypnea (\<7 breaths/min), tachypnea (\>30 breaths/min), tachycardia (heart rate \>130 beats/min), and bradycardia (heart rate \<45 beats/min). These exposure thresholds represent a balance between events that are clinically meaningful and excessive alarms that will discourage clinician participation. The investigators expect about 1 alert per patient per day with these thresholds, with most being considered informative or actionable by nurses. In unblinded patients, clinician alerts will be activated at these thresholds.

Interventions

  • DEVICE Blinded continuous vital sign monitoring
  • DEVICE Unblinded continuous vital sign monitoring

Trial Details

FieldValue
Enrollment Target 492 participants
Start Date 2026-06-01
Est. Completion 2029-03-01
Phase NA

What the Registry Record Tells You About NCT06232876

The ClinicalTrials.gov registry entry for NCT06232876 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 492 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Blinded continuous vital sign monitoring is the first listed.

NCT06232876 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT06232876 about?

NCT06232876 is a clinical study titled "Continuous Versus Intermittent Ward Monitoring". The investigators will randomize adults having major non-cardiac inpatient surgery to blinded versus unblinded continuous postoperative vital sign monitoring (saturation, ventilation, and heart rate). The investigators will use a wearable, untethered, and battery-powered sensor (Masimo Radius PPG, M...

What is the current status of trial NCT06232876?

This trial is currently not yet recruiting. It is a NA study. The enrollment target is 492 participants. The study started on 2026-06-01. Estimated completion is 2029-03-01.

What interventions are being tested in trial NCT06232876?

The interventions under investigation include: Blinded continuous vital sign monitoring (DEVICE), Unblinded continuous vital sign monitoring (DEVICE).

Who is sponsoring clinical trial NCT06232876?

This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.